NCT07281664 2025-12-15
Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University
Phase NA Not yet recruiting
Clinical Trials
16 trialsNCT07272265 2025-12-09
The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study
Sun Yat-sen University
Phase NA Completed
NCT06893887 2025-07-02
ICT-HCC
Nanjing Tianyinshan Hospital
Phase NA Recruiting
NCT01792934 2025-04-15
ORCHESTRA
Radboud University Medical Center
Phase NA Active not recruiting
NCT04180072 2024-07-05
Atezolizumab Plus Bevacizumab With HCC and HBV Infection
National Health Research Institutes, Taiwan
Phase NA Active not recruiting
NCT06265350 2024-02-20
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
Sun Yat-sen University
Phase NA Recruiting
NCT06177288 2023-12-20
DEBIRI
Fudan University
Phase NA Unknown
NCT06035133 2023-09-13
Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy
Tang-Du Hospital
Phase NA Not yet recruiting
NCT03743428 2023-06-29
BABST-C
Shenzhen People's Hospital
Phase NA Suspended
NCT02256800 2021-11-17
Escalated Dose of Irinotecan in mCRC
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Completed
NCT01280643 2021-03-15
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Fox Chase Cancer Center
Phase NA Terminated
NCT00462501 2016-01-20
Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00537901 2015-12-17
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
King Faisal Specialist Hospital & Research Center
Phase NA Completed
NCT01405430 2015-06-29
AVECC
Centre Leon Berard
Phase NA Completed
NCT00826800 2015-04-15
Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Terminated
NCT00524069 2013-02-01
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Roswell Park Cancer Institute
Phase NA Withdrawn